Company Filing History:
Years Active: 2008
Title: Terese Solstad: Innovator in Bioactive Peptide Production
Introduction
Terese Solstad is a prominent inventor based in Tromsø, Norway. She has made significant contributions to the field of biotechnology, particularly in the development of bioactive peptides. Her innovative work has the potential to impact therapeutic applications, especially in cancer treatment.
Latest Patents
Terese Solstad holds a patent for "Methods of peptide preparation." This invention relates to a method of producing a bioactive peptide that is 7 to 25 amino acids in length, containing at least 3 cationic amino acids, and capable of forming an amphipathic α-helix. The method involves identifying a cationic sector and dividing the remaining part of the peptide into three equal sectors. It also incorporates at least 60% of the bulk and lipophilicity provided by the amino acid R groups into the sectors flanking the cationic sector. The peptides produced through this method have potential uses in therapy, particularly for treating benign or malignant tumors.
Career Highlights
Terese Solstad is associated with Lytix Biopharma, a company focused on developing innovative cancer therapies. Her work at Lytix Biopharma has positioned her as a key player in the biotechnology sector, contributing to advancements in peptide-based treatments.
Collaborations
Throughout her career, Terese has collaborated with notable colleagues, including Øystein Rekdal and John Sigurd Svendsen. These collaborations have further enhanced her research and development efforts in the field of bioactive peptides.
Conclusion
Terese Solstad's contributions to the field of bioactive peptide production exemplify her innovative spirit and dedication to advancing therapeutic solutions. Her work continues to inspire future research in biotechnology and cancer treatment.